Retatrutide 20 mg — research reference
Storage specifications, vial concentration information, reconstitution math, handling guidance, and batch documentation for RT20.
Specimen specification
RT20 is supplied lyophilised in a sealed glass vial under an aluminium seal. Net content and purity for the current lot are recorded on the certificate of analysis and reproduced on the specimen page in the Vault.
20 mg concentration reference
Total material (mg) ÷ total solution volume (mL) = concentration (mg/mL)
For a 20 mg vial, 2 mL of bacteriostatic water is recommended — yielding a 10 mg/mL solution. This volume balances measurement precision with handling convenience on a standard 100-unit (1 mL) insulin syringe.
Based on a 100-unit (1 mL) insulin syringe.
How much material a single unit delivers.
Standard insulin syringe graduation.
Enter a target amount of material to see the equivalent syringe units for the reconstituted solution above.
Laboratory concentration calculation only. No dosing, administration or protocol guidance is provided.
Storage specification
Sealed lyophilised vials are held refrigerated at 2–8 °C, protected from light. Extended archival storage is held frozen. Once in solution, material is refrigerated and treated as a short-lived working solution.
Avoid repeated freeze–thaw cycling and prolonged exposure to ambient temperature or direct light.
Handling guidance
Introduce diluent slowly against the inside wall of the vial and swirl gently until the cake has fully dissolved. Do not shake. Inspect for clarity before use; discard material showing particulates or discolouration.
Batch documentation
Each lot carries third-party analytical documentation covering identity, purity and net content. Current lot records and verification links are published in the certificates archive.
Laboratory reference only. Seven Saints products are intended for research use and are not intended to diagnose, treat, cure, or prevent disease or for human consumption.